Breaking News
November 16, 2018 - AHA: PTSD Common Among Those Who Suffer Tear in the Aorta’s Wall
November 16, 2018 - Many RA patients’ pain related to central nervous system
November 16, 2018 - Changes in Himalayan gut microbiomes linked to diet
November 16, 2018 - Inhibition of prostaglandin E2 enhances ability to combat infectious colitis
November 16, 2018 - Chronic dry eye can slow reading rate and disrupt day to day tasks
November 16, 2018 - Researchers develop new drug molecule that inhibits inflammation
November 16, 2018 - Dementia symptoms peak in winter and spring, study finds
November 16, 2018 - Stanford tobacco researcher weighs in on JUUL
November 16, 2018 - Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds
November 16, 2018 - Researchers find no link between infants waking up at night and later developmental problems
November 16, 2018 - Both parents and children agree about confidential medical services
November 16, 2018 - FDA warns against use of unapproved pain medications with implanted pumps
November 16, 2018 - Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer’s disease
November 16, 2018 - Study provides new insight into norovirus outbreaks, may help guide efforts to develop vaccines
November 16, 2018 - Inexpensive, portable air purifier could help protect the heart from pollution
November 16, 2018 - New 15-minute scan could help diagnose brain damage in babies up to two years old
November 16, 2018 - Deep brain stimulation not effective for treating early Alzheimer’s
November 16, 2018 - Traditional chemotherapy superior to new alternative for oropharyngeal cancers | News Center
November 16, 2018 - What This Pond Protist Does With Its Genome Will Astound You
November 15, 2018 - Researchers develop tool that speeds up analysis and publication of biomedical data
November 15, 2018 - Scientists identify mechanism used by lung cancer cells to obtain glucose
November 15, 2018 - Abnormalities in development of the brain could be involved in onset of autism, finds new study
November 15, 2018 - Soy protein equally effective as animal protein in building muscle strength
November 15, 2018 - American Academy of Pediatrics, Nov. 2-6
November 15, 2018 - Dopamine drives early addiction to heroin
November 15, 2018 - Variance in gut microbiome in Himalayan populations linked to dietary lifestyle | News Center
November 15, 2018 - Reducing Cardiovascular Disease: The Amish Way
November 15, 2018 - King’s researchers launch charter to guide organizations to engage abuse survivors in research
November 15, 2018 - Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals
November 15, 2018 - TGen North collaborates with NARBHA Institute to advance human health
November 15, 2018 - Researchers discover molecular basis for therapeutic actions of an African folk medicine
November 15, 2018 - Human Cell Atlas study of early pregnancy shows how mother’s immune system is modified
November 15, 2018 - New guidelines for detecting and managing sarcopenia to be launched in the UK
November 15, 2018 - Researchers explore role of dietary composition on energy expenditure
November 15, 2018 - Elsevier launches Entellect™ Platform, unlocking value by creating AI-ready life sciences data
November 15, 2018 - Now that cannabis is legal in Canada, let’s use it to tackle the opioid crisis
November 15, 2018 - In the Spotlight: At the intersection of tech, health, and ethics
November 15, 2018 - Traditional Glaucoma Test Can Miss Severity of the Disease
November 15, 2018 - Researchers directly connect activities of genes with instinctive behavior in male cichlids
November 15, 2018 - Salk researchers report new methods to identify AD drug candidates with anti-aging properties
November 15, 2018 - St. Jude Hospital announces availability of largest collections of leukemia samples
November 15, 2018 - Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline
November 15, 2018 - Designing a novel cell-permeable peptide chimera to promote wound healing
November 15, 2018 - NEI investigators combine two imaging modalities to view the retina in unprecedented detail
November 15, 2018 - Determining how hearts develop to better understand congenital heart defects
November 15, 2018 - Maverick immune cells can act independently to identify and kill cancer cells, finds research
November 15, 2018 - Advanced AI and big data methods to tackle dementia
November 15, 2018 - Report reveals increase in pancreatic cancer death rates across Europe
November 15, 2018 - Luxia Scientific announces availability of its gut microbiome test in Luxembourg
November 15, 2018 - New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis
November 15, 2018 - New approach targets matrix surrounding neurons to protect neurons after stroke
November 15, 2018 - Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine
November 15, 2018 - Heart failure patients shouldn’t stop meds even if condition improves: study
November 15, 2018 - Parents and carers of people with diabetes experience emotional or mental health problems
November 15, 2018 - RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders
November 15, 2018 - Breakthrough research could lead to a new wave of cancer-fighting antibodies
November 15, 2018 - Mylan and Biocon launch new insulin glargine biosimilar in the UK
November 15, 2018 - For wildfire safety, only particular masks guard against toxic particulate matter
November 15, 2018 - New study of tribe shows influence of Western diet and lifestyle on blood pressure
November 15, 2018 - Scientists harness power of natural killer cells to treat children with neuroblastoma
November 15, 2018 - Investigating foodborne disease outbreak in Bosnia and Herzegovina based on simulation game
November 15, 2018 - Recommendations Issued for Management of Bradycardia
November 15, 2018 - Benefit unclear due to a lack of suitable studies
November 15, 2018 - TAMEST recognizes UT Southwestern’s Ralph DeBerardinis for changing our understanding of cancer
November 15, 2018 - Researchers discover key factors behind intestinal inflammation in CVID patients
November 15, 2018 - CityU develops first microarrayed 3D neuronal culture platform
November 15, 2018 - Expert suggests ways to control uncomfortable vaginal symptoms in diabetic women
November 15, 2018 - New edition of Red Journal focuses on roles of imaging in radiation oncology
November 15, 2018 - Doctors Aren’t Promoting Breastfeeding’s Cancer-Protection Benefit
November 15, 2018 - Collection of demonstration projects highlights value of patient engagement in research
November 15, 2018 - Technique to ‘listen’ to a patient’s brain during tumour surgery
November 15, 2018 - Seven-year-old returns to life as a “normal, healthy child” following bone marrow transplant
November 15, 2018 - AMSBIO expands range of high quality FFPE cancer cell line controls
November 15, 2018 - Marijuana use by kidney donors has no effect on transplant outcomes
November 15, 2018 - Exploring NMR Spectroscopy Applications through Interesting Infographics
November 15, 2018 - Chapman University wins additional $2.9 million NIH grant to study Alzheimer’s disease
November 15, 2018 - Microgel powder reduces infection and promotes healing
November 15, 2018 - Suicidal patients with prescribed access to psychotropic drugs should be closely monitored
November 15, 2018 - Nitric oxide-releasing technology shows potential to reduce healing time of diabetic foot ulcers
November 15, 2018 - Mass shootings may trigger unnecessary blood donations
Cook Regentec collaborates with Indiana University School of Medicine to develop new techmologies

Cook Regentec collaborates with Indiana University School of Medicine to develop new techmologies

image_pdfDownload PDFimage_print

Cook Regentec, Cook Group’s first company in Indianapolis, cut the ribbon Wednesday on its new facility on Indiana Avenue and announced a collaboration with Indiana University School of Medicine aimed at developing tools and technologies that advance solutions in the emerging areas of immunotherapy, precision medicine, drug delivery, regenerative medicine and bioprinting.

Cook Regentec develops and commercializes research and clinical tools to advance regenerative medicine therapies. The company celebrated the completion of the transformation and rehabilitation of a former beer warehouse into a 22,000-square-foot innovation center with modern, collaborative office space and adjacent advanced laboratory facilities.

Founded in 2015 as an incubator/accelerator for biological and device innovations, Cook Regentec has created three early stage companies that have already commercialized 12 different products, including cellular growth media, solutions for cryopreservation and medical devices for the delivery of therapeutic agents.

The relationship with Indiana University School of Medicine delivers on Cook Regentec’s mission to leverage the Indianapolis life sciences and advanced industry ecosystem to continue developing and commercializing new technologies across industries and disciplines. Cook Regentec scientists, engineers and product developers will connect with Indiana University School of Medicine researchers and scientists at The Collaboratory @ Cook Regentec. The new collaboration space is a 6,000-square-foot idea lab and collaborative technology incubator located at Cook Regentec’s newly rehabilitated Indianapolis headquarters.

The teams will address unmet needs in the fields of cell and gene therapy and regenerative medicine. Research scientists, clinicians and biopharma companies worldwide use revolutionary cell and gene therapy approaches to uncover new and improved treatments for patients. Cook Regentec works alongside them to develop tools and technologies to address the specialized production, storage and delivery requirements of living cellular medicines.

“As an incubator and accelerator, Cook Regentec is in relentless pursuit of the best ideas and collaborations that will help us innovate technologies and create new ventures that make medicine better for patients,” said Rob Lyles, president of Cook Regentec. “Our working relationship with Indiana University School of Medicine leverages the deep expertise of the nation’s largest medical school and Cook Regentec’s entrepreneurial and multi-disciplinary approach to technology and product development.”

Cook Regentec has a proven record for the development and commercialization of emerging technologies and Indiana University School of Medicine has a long history of developing and testing new therapies for patients. In recent years the school has made aggressive investments in faculty expertise, infrastructure and technology necessary to make research breakthroughs in the emerging fields of cell and gene therapy through the IU Precision Health Initiative and with the establishment of its new Indiana Center for Regenerative Medicine and Engineering and Brown Center for Immunotherapy.

Cook Regentec and Indiana University School of Medicine will be the first collaboration team to use The Collaboratory @ Cook Regentec innovation space and plan to jointly focus on a number of key areas in need of enabling technologies. Initial collaborative projects may include battlefield and trauma applications of bioprocessing tools, targeted delivery of advanced biologic medicines, advanced bioprocessing technologies and molecular tools for the production of engineered cell lines and novel bioprinting applications.

“As a medical school, we are driven to develop new therapies for patients who are affected by devastating and life-threatening illnesses and injuries,” said Dr. Jay L. Hess, dean of IU School of Medicine and IU’s executive vice president for university clinical affairs. “This exciting new opportunity will enable us to tap into Cook Regentec’s extraordinary expertise to ensure those discoveries are commercially viable and can be delivered to patients as efficiently as possible.”

The collaboration with Indiana University School of Medicine represents the type of connections Cook Regentec envisioned when it chose Indianapolis for its newest venture. Its employees are within walking distance of central Indiana’s core research assets, including the medical school and its Indiana Center for Regenerative Medicine and Engineering, the Indiana Biosciences Research Institute, and the 16 Tech Innovation District.

“At its core, 16 Tech is an innovation hub, where creative thinkers and doers across the life sciences, tech and advanced engineering industries will collaborate and innovate,” said Bob Coy, president and CEO of 16 Tech Community Corporation, the nonprofit operating entity for the 60-acre 16 Tech Innovation District. “Cook Regentec and the Indiana University School of Medicine have launched the exact type of collaborative relationship we expect to ignite at 16 Tech. We’re looking forward to seeing the outcomes of this great partnership and the additional collaborations yet to emerge.”​

Source:

Home

Tagged with:

About author

Related Articles